Skip to content
NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP

3M Co. MMM

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$24.9B
▲ 1.5% YoY
$3.2B
▼ 22.1% YoY
$1.4B
▲ 118.8% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Its business segments bring together common or related 3M technologies, which supports the development of products and services and the sharing of business resources across the Company. 3M products are sold through numerous distribution channels, including directly to users and through e-commerce, wholesalers, retailers, jobbers, distributors, and dealers in many countries. On December 31, 2025, the Company employed approximately 60,500 people, with approximately 22,500 employed in the United States and 38,000 employed internationally. The Company owns, or holds licenses to use, numerous U.S. and foreign patents. 3M Company was incorporated in 1929 under the laws of the State of Delaware to continue operations begun in 1902.

Written from the business description in 3M COMPANY's annual report to the U.S. Securities and Exchange Commission, filed 3 February 2026. Every sentence was checked against that document before publication.

Growth

USD 24.9B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 24.9 · Net income 3.2
15.0B30.0B-2.5B-5.0B
2007201020132016201920222025
Compound annual growth
−1.6%
−5.0%
−1.9%
−0.4%
−17.4%
−9.8%
−3.9%
−1.5%
−16.2%
−8.5%
−2.3%
+0.4%
−21.2%
−13.1%
−0.5%
+2.2%
−0.1%
+5.1%
−4.7%
+4.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −5.0% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

13 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 18.6% · Net 13.1%
10%20%-20%-40%
200720162025
ROE
FY2025 · ROE 76.1%
50%-20%-40%-60%
200720162025
Three returns, three denominators.

Each USD of equity produced 76 cents of profit this year.

Cash & shareholders

USD 4.8B
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 1.4
2.5B5.0B
200720162025
Net buybacks $B Dividends $B
FY2025 · Dividends 1.6 · Net buybacks 3.3
3B6BDividendsNet buybacks
2007201020132016201920222025

USD 1.6B in dividends and USD 3.3B in buybacks — 148% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 37.7B
EquityUSD 4.7B
CashUSD 5.2B
Gross debtUSD 12.6B
Net debtUSD 7.4B
Current ratio1.71×

Net debt stands at 157% of equity.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
MMM, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B24.924.624.626.235.432.232.132.831.730.130.331.830.929.929.626.723.125.324.5
Operating income $B4.64.8−10.74.47.47.26.27.27.77.06.97.16.76.56.25.94.85.26.2
EBITDA $B5.96.2−8.76.29.39.17.88.79.28.58.48.58.07.87.47.06.06.4◌
Income tax $B1.00.8−2.90.21.31.31.11.62.72.02.02.01.81.81.71.61.41.62.0
Net income $B3.24.2−7.05.85.95.44.55.34.95.04.85.04.74.44.34.13.23.54.1
Free cash flow $B1.40.65.13.85.96.65.44.94.95.25.05.14.23.83.94.14.03.12.8
EPS, diluted $6.007.55−12.6310.1810.129.367.728.897.938.167.587.496.726.325.965.634.524.895.60
Dividend / sh $2.923.616.005.965.925.885.765.444.704.443.083.593.402.362.202.102.042.001.92
Payout %4847−4758586273605853534537373637454034
ROE %76.196.5−71.638.842.447.545.550.144.446.539.432.426.626.927.628.728.231.533.9
Shares out B0.530.540.550.550.570.580.580.580.590.600.610.640.660.690.690.710.710.69◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

Compare

This company against its peers

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 74 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Two checks were skipped: the balance sheet is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image